Results 301 to 309 of about 47,200 (309)
Some of the next articles are maybe not open access.

Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

The Lancet, 2018
P. Devereaux   +239 more
semanticscholar   +1 more source

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

Thrombosis and Haemostasis, 2010
J. Ryn   +6 more
semanticscholar   +1 more source

Idarucizumab for the Reversal of Dabigatran

Annals of Emergency Medicine, 2017
Michael Gottlieb, Basem F. Khishfe
openaire   +3 more sources

Dabigatran: laboratory monitoring

Pathology, 2012
George Chan   +2 more
openaire   +3 more sources

Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran

Advances in Therapy, 2020
P. Zubiaur   +9 more
semanticscholar   +1 more source

Adverse Effects of Dabigatran

Annals of Internal Medicine, 2012
openaire   +3 more sources

Antidot gegen Dabigatran [PDF]

open access: possibleInFo Neurologie & Psychiatrie, 2015
openaire   +2 more sources

On the Cost-effectiveness of Dabigatran

Revista Española de Cardiología (English Edition), 2013
openaire   +3 more sources

Home - About - Disclaimer - Privacy